July 24, 2018
This is a consensus DNA vaccine providing protection against Influenza D in cattle.
This technology is a vaccine that provides protection against Influenza D (IDV). IDV is a major contributor to bovine respiratory disease complex (BRDC), one of the most commonly diagnosed cause of morbidity and mortality within the cattle industry. There are currently no vaccines which provide full and effective protection against BRDC. This vaccine is a DNA consensus vaccine that carries IDV hemagglutinin esterase fusion (HEF) protein. This vaccine increases neutralizing antibodies against IDV and prevents accumulation of two IDV lineages in guinea pigs.
• Consensus DNA hemagglutinin esterase fusion (HEF) protein vaccine conferring resistance to Influenza D Virus
NUtech Ventures is the non-profit technology commercialization affiliate of the University of Nebraska–Lincoln. Our mission is to facilitate the commercialization and practical use of innovations generated through the research activities at the University of Nebraska.
• Animal Health: Vaccine
• Increased Protection: Provides protection against IDV, thereby reducing cattle mortality by BRDC Benefit(s)
• Efficient: Potentially protect against several different strains of IDV
由于技术保密工作限制，技术信息无法完全展现，请通过邮箱或短信联系我们，获取更多技术资料。
dna consensus vaccine
B5, No.1600, North Guoquan Rd, Yangpu, Shanghai
info@yintrust.com
021-65679356
Premium